Product Code: ETC13252355 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Coronary Stent Market was valued at USD 9.7 Billion in 2024 and is expected to reach USD 14.6 Billion by 2031, growing at a compound annual growth rate of 7.12% during the forecast period (2025-2031).
The global coronary stent market is experiencing steady growth driven by an increasing prevalence of cardiovascular diseases, advancements in stent technology, and a growing aging population. The market is characterized by the presence of key players such as Medtronic, Abbott Laboratories, and Boston Scientific Corporation, who are constantly innovating to introduce new products with improved efficacy and safety profiles. Drug-eluting stents dominate the market due to their ability to reduce restenosis rates compared to bare-metal stents. Emerging markets in Asia-Pacific and Latin America are expected to offer significant growth opportunities for market expansion. However, stringent regulations, high costs associated with stent procedures, and the availability of alternative treatments such as bypass surgery may pose challenges to the market`s growth in the coming years.
The Global Coronary Stent Market is experiencing significant growth driven by factors such as the rising prevalence of cardiovascular diseases, technological advancements in stent design, and increasing demand for minimally invasive procedures. Key trends in the market include the shift towards bioresorbable stents, the development of drug-eluting stents with improved efficacy and safety profiles, and the emergence of specialized stents for complex coronary lesions. Opportunities for market players lie in expanding their product portfolios to cater to diverse patient populations, enhancing their distribution channels in emerging markets, and investing in research and development to introduce innovative stent technologies. With the increasing adoption of coronary stents for the treatment of coronary artery disease, the Global Coronary Stent Market is poised for continued growth and innovation in the coming years.
The Global Coronary Stent Market faces several challenges, including intense competition among key players leading to pricing pressures and reduced profit margins. Regulatory hurdles and stringent approval processes for new stent products also pose challenges for market growth. The market is highly dynamic with rapid technological advancements, requiring companies to continuously invest in research and development to stay competitive. Additionally, the increasing preference for non-invasive treatment options like drug therapy and lifestyle modifications presents a threat to the demand for coronary stents. Furthermore, the ongoing shift towards value-based healthcare systems and cost-containment measures in various countries add complexity to market dynamics, influencing purchasing decisions and reimbursement policies for coronary stent procedures. Overall, navigating these challenges while maintaining innovation and cost-effectiveness is crucial for companies operating in the Global Coronary Stent Market.
The Global Coronary Stent Market is primarily driven by the increasing prevalence of cardiovascular diseases, particularly coronary artery disease, across the world. The rising geriatric population, unhealthy lifestyle choices leading to conditions like obesity and diabetes, and the growing adoption of sedentary habits are contributing to the higher incidence of heart-related issues. Additionally, advancements in stent technologies, such as drug-eluting stents and bioresorbable stents, are driving market growth by offering improved efficacy and patient outcomes. Furthermore, increasing awareness about minimally invasive procedures, better healthcare infrastructure in developing countries, and the expanding healthcare expenditure are also fueling the demand for coronary stents globally.
Government policies related to the Global Coronary Stent Market primarily focus on regulating the safety, efficacy, and quality of coronary stents to ensure patient safety. Regulatory bodies such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in the European Union set stringent requirements for the approval and marketing of coronary stents, including extensive clinical trials and post-market surveillance. These regulations aim to prevent adverse events, ensure proper labeling and instructions for use, and promote transparency in the industry. Additionally, reimbursement policies in various countries play a crucial role in market access for coronary stents, influencing pricing strategies and market dynamics. Overall, government policies in the Global Coronary Stent Market are geared towards safeguarding public health and promoting innovation in medical devices.
The Global Coronary Stent Market is projected to experience steady growth in the coming years, driven by factors such as the increasing prevalence of coronary artery diseases, rising geriatric population, and advancements in stent technologies. The market is expected to witness a shift towards bioresorbable stents, as they offer reduced risk of long-term complications compared to traditional metallic stents. Additionally, the growing adoption of minimally invasive procedures and improved healthcare infrastructure in emerging economies are further expected to contribute to market growth. However, factors such as stringent regulations and high costs associated with coronary stent procedures may pose challenges to market expansion. Overall, the Global Coronary Stent Market is anticipated to see sustained growth, with key players focusing on innovation and strategic partnerships to maintain a competitive edge.
In the global coronary stent market, Asia is expected to witness significant growth due to the rising prevalence of cardiovascular diseases and improving healthcare infrastructure. North America is a key market driven by technological advancements and high healthcare expenditure. In Europe, the market is mature with a focus on innovative stent technologies and increasing adoption of minimally invasive procedures. The Middle East and Africa region is experiencing a growing demand for coronary stents due to improving access to healthcare services and increasing awareness about heart diseases. Latin America is also showing promising growth opportunities driven by the increasing geriatric population and changing lifestyle habits leading to a rise in cardiovascular disorders. Overall, the global coronary stent market is characterized by regional variations in market dynamics and growth drivers.
Global Coronary Stent Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Coronary Stent Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Coronary Stent Market Revenues & Volume, 2021 & 2031F |
3.3 Global Coronary Stent Market - Industry Life Cycle |
3.4 Global Coronary Stent Market - Porter's Five Forces |
3.5 Global Coronary Stent Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Coronary Stent Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Coronary Stent Market Revenues & Volume Share, By Biomaterial, 2021 & 2031F |
3.8 Global Coronary Stent Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Global Coronary Stent Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Coronary Stent Market Trends |
6 Global Coronary Stent Market, 2021 - 2031 |
6.1 Global Coronary Stent Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Coronary Stent Market, Revenues & Volume, By Drug-Eluting Stent, 2021 - 2031 |
6.1.3 Global Coronary Stent Market, Revenues & Volume, By Bare Metal Coronary Stent, 2021 - 2031 |
6.1.4 Global Coronary Stent Market, Revenues & Volume, By Bioabsorbable Stent, 2021 - 2031 |
6.2 Global Coronary Stent Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Coronary Stent Market, Revenues & Volume, By Metallic Biomaterial, 2021 - 2031 |
6.2.3 Global Coronary Stent Market, Revenues & Volume, By Polymeric Biomaterial, 2021 - 2031 |
6.2.4 Global Coronary Stent Market, Revenues & Volume, By Natural Biomaterial, 2021 - 2031 |
6.3 Global Coronary Stent Market, Revenues & Volume, By End-users, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Coronary Stent Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Coronary Stent Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
7 North America Coronary Stent Market, Overview & Analysis |
7.1 North America Coronary Stent Market Revenues & Volume, 2021 - 2031 |
7.2 North America Coronary Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Coronary Stent Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Coronary Stent Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
7.5 North America Coronary Stent Market, Revenues & Volume, By End-users, 2021 - 2031 |
8 Latin America (LATAM) Coronary Stent Market, Overview & Analysis |
8.1 Latin America (LATAM) Coronary Stent Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Coronary Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Coronary Stent Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Coronary Stent Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
8.5 Latin America (LATAM) Coronary Stent Market, Revenues & Volume, By End-users, 2021 - 2031 |
9 Asia Coronary Stent Market, Overview & Analysis |
9.1 Asia Coronary Stent Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Coronary Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Coronary Stent Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Coronary Stent Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
9.5 Asia Coronary Stent Market, Revenues & Volume, By End-users, 2021 - 2031 |
10 Africa Coronary Stent Market, Overview & Analysis |
10.1 Africa Coronary Stent Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Coronary Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Coronary Stent Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Coronary Stent Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
10.5 Africa Coronary Stent Market, Revenues & Volume, By End-users, 2021 - 2031 |
11 Europe Coronary Stent Market, Overview & Analysis |
11.1 Europe Coronary Stent Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Coronary Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Coronary Stent Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Coronary Stent Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
11.5 Europe Coronary Stent Market, Revenues & Volume, By End-users, 2021 - 2031 |
12 Middle East Coronary Stent Market, Overview & Analysis |
12.1 Middle East Coronary Stent Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Coronary Stent Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Coronary Stent Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Coronary Stent Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Coronary Stent Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
12.5 Middle East Coronary Stent Market, Revenues & Volume, By End-users, 2021 - 2031 |
13 Global Coronary Stent Market Key Performance Indicators |
14 Global Coronary Stent Market - Export/Import By Countries Assessment |
15 Global Coronary Stent Market - Opportunity Assessment |
15.1 Global Coronary Stent Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Coronary Stent Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Coronary Stent Market Opportunity Assessment, By Biomaterial, 2021 & 2031F |
15.4 Global Coronary Stent Market Opportunity Assessment, By End-users, 2021 & 2031F |
16 Global Coronary Stent Market - Competitive Landscape |
16.1 Global Coronary Stent Market Revenue Share, By Companies, 2024 |
16.2 Global Coronary Stent Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |